FITC-dextran, 4Kda
To Order Contact us: [email protected]
FITC-labeled Dextran (MW10, 000) |
|||
| ST2935-50mg | Beyotime Biotech Inc | 50 mg | Ask for price |
FITC-labeled Dextran (MW40, 000) |
|||
| ST2940-250mg | Beyotime Biotech Inc | 250 mg | Ask for price |
FITC-labeled Dextran (MW40, 000) |
|||
| ST2940-50mg | Beyotime Biotech Inc | 50 mg | Ask for price |
FITC-labeled Dextran (MW70, 000) |
|||
| ST2947-250mg | Beyotime Biotech Inc | 250 mg | Ask for price |
FITC-labeled Dextran (MW70, 000) |
|||
| ST2947-50mg | Beyotime Biotech Inc | 50 mg | Ask for price |
FITC-labeled Dextran (MW150, 000) |
|||
| ST2955-1g | Beyotime Biotech Inc | 1 g | Ask for price |
FITC-labeled Dextran (MW150, 000) |
|||
| ST2955-250mg | Beyotime Biotech Inc | 250 mg | Ask for price |
FITC-labeled Dextran (MW150, 000) |
|||
| ST2955-50mg | Beyotime Biotech Inc | 50 mg | Ask for price |
Dextran 200,000 |
|||
| GC9974 | Glentham Life Sciences | 25g | EUR 141.53 |
Dextran 200,000 |
|||
| GC9974-100 | Glentham Life Sciences | 100 | EUR 154.6 |
Dextran 200,000 |
|||
| GC9974-25 | Glentham Life Sciences | 25 | EUR 62 |
Dextran 250,000 |
|||
| GC7757 | Glentham Life Sciences | 25g | EUR 131.15 |
Dextran 250,000 |
|||
| GC7757-100 | Glentham Life Sciences | 100 | EUR 143.2 |
Dextran 250,000 |
|||
| GC7757-25 | Glentham Life Sciences | 25 | EUR 57.2 |
Dextran 100,000 |
|||
| GC6054 | Glentham Life Sciences | 100g | EUR 217.3 |
Dextran 100,000 |
|||
| GC6054-100 | Glentham Life Sciences | 100 | EUR 118.7 |
Dextran 100,000 |
|||
| GC6054-250 | Glentham Life Sciences | 250 | EUR 237.2 |
Dextran 5000 |
|||
| D7270 | Solarbio Life Science |
|
|
Dextran 10000 |
|||
| D7280 | Solarbio Life Science |
|
|
2000 kDa Amino Dextran |
|||
| AD2000x100 | Fina Biosolutions LLC |
|
|
|
Description: Amino-Dextran (AmDex, AECM-dextran) consists of dextran functionalized with primary amines. (See “Diagram” Tab for the structure of FinaBio amino dextran.) Our AmDex is prepared from dextran using a protocol yielding a stable, amino functionalized dextran that is superior to the more commonly used reductive amination methods. The molecular weight profile of Fina Biosolutions’ AmDex is essentially unchanged from the starting dextran, as determined by analytical size exclusion chromatography. The product is desalted and lyophilized. We do extensive processing and testing to ensure that free amino reagent is removed, resulting in a consistent product with minimal lot-to-lot variation. We have found that many commercial lots of amino-dextran contain variable amounts of dextran and that the amine content is often incorrect. Furthermore, the actual polymer molecular weight distributions of these preparations can vary extensively from the indicated molecular weight. These issues can mean that optimization data is based on incorrect information. Lot-to-lot variations means that protocols may need to be revised when a new lot of AmDex is used. Please contact us if you need a ratio that is not listed. |
|||
2000 kDa Amino Dextran |
|||
| AD2000x1000 | Fina Biosolutions LLC |
|
|
|
Description: Amino-Dextran (AmDex, AECM-dextran) consists of dextran functionalized with primary amines. (See “Diagram” Tab for the structure of FinaBio amino dextran.) Our AmDex is prepared from dextran using a protocol yielding a stable, amino functionalized dextran that is superior to the more commonly used reductive amination methods. The molecular weight profile of Fina Biosolutions’ AmDex is essentially unchanged from the starting dextran, as determined by analytical size exclusion chromatography. The product is desalted and lyophilized. We do extensive processing and testing to ensure that free amino reagent is removed, resulting in a consistent product with minimal lot-to-lot variation. We have found that many commercial lots of amino-dextran contain variable amounts of dextran and that the amine content is often incorrect. Furthermore, the actual polymer molecular weight distributions of these preparations can vary extensively from the indicated molecular weight. These issues can mean that optimization data is based on incorrect information. Lot-to-lot variations means that protocols may need to be revised when a new lot of AmDex is used. Please contact us if you need a ratio that is not listed. |
|||
2000 kDa Amino Dextran |
|||
| AD2000x250 | Fina Biosolutions LLC |
|
|
|
Description: Amino-Dextran (AmDex, AECM-dextran) consists of dextran functionalized with primary amines. (See “Diagram” Tab for the structure of FinaBio amino dextran.) Our AmDex is prepared from dextran using a protocol yielding a stable, amino functionalized dextran that is superior to the more commonly used reductive amination methods. The molecular weight profile of Fina Biosolutions’ AmDex is essentially unchanged from the starting dextran, as determined by analytical size exclusion chromatography. The product is desalted and lyophilized. We do extensive processing and testing to ensure that free amino reagent is removed, resulting in a consistent product with minimal lot-to-lot variation. We have found that many commercial lots of amino-dextran contain variable amounts of dextran and that the amine content is often incorrect. Furthermore, the actual polymer molecular weight distributions of these preparations can vary extensively from the indicated molecular weight. These issues can mean that optimization data is based on incorrect information. Lot-to-lot variations means that protocols may need to be revised when a new lot of AmDex is used. Please contact us if you need a ratio that is not listed. |
|||
2000 kDa Amino Dextran |
|||
| AD2000x500 | Fina Biosolutions LLC |
|
|
|
Description: Amino-Dextran (AmDex, AECM-dextran) consists of dextran functionalized with primary amines. (See “Diagram” Tab for the structure of FinaBio amino dextran.) Our AmDex is prepared from dextran using a protocol yielding a stable, amino functionalized dextran that is superior to the more commonly used reductive amination methods. The molecular weight profile of Fina Biosolutions’ AmDex is essentially unchanged from the starting dextran, as determined by analytical size exclusion chromatography. The product is desalted and lyophilized. We do extensive processing and testing to ensure that free amino reagent is removed, resulting in a consistent product with minimal lot-to-lot variation. We have found that many commercial lots of amino-dextran contain variable amounts of dextran and that the amine content is often incorrect. Furthermore, the actual polymer molecular weight distributions of these preparations can vary extensively from the indicated molecular weight. These issues can mean that optimization data is based on incorrect information. Lot-to-lot variations means that protocols may need to be revised when a new lot of AmDex is used. Please contact us if you need a ratio that is not listed. |
|||
2000 kDa Amino Dextran |
|||
| AD2000x750 | Fina Biosolutions LLC |
|
|
|
Description: Amino-Dextran (AmDex, AECM-dextran) consists of dextran functionalized with primary amines. (See “Diagram” Tab for the structure of FinaBio amino dextran.) Our AmDex is prepared from dextran using a protocol yielding a stable, amino functionalized dextran that is superior to the more commonly used reductive amination methods. The molecular weight profile of Fina Biosolutions’ AmDex is essentially unchanged from the starting dextran, as determined by analytical size exclusion chromatography. The product is desalted and lyophilized. We do extensive processing and testing to ensure that free amino reagent is removed, resulting in a consistent product with minimal lot-to-lot variation. We have found that many commercial lots of amino-dextran contain variable amounts of dextran and that the amine content is often incorrect. Furthermore, the actual polymer molecular weight distributions of these preparations can vary extensively from the indicated molecular weight. These issues can mean that optimization data is based on incorrect information. Lot-to-lot variations means that protocols may need to be revised when a new lot of AmDex is used. Please contact us if you need a ratio that is not listed. |
|||
Dextran |
|||
| 01341-10 | Polysciences Europe GmbH | 10g | EUR 61.56 |
|
Description: 9004-54-0 |
|||
Dextran |
|||
| 01341-100 | Polysciences Europe GmbH | 100g | EUR 233.28 |
|
Description: 9004-54-0 |
|||
Dextran |
|||
| 10910-12 | NACALAI TESQUE | 25G | EUR 35.35 |
Dextran |
|||
| 10910-25 | NACALAI TESQUE | 500G | EUR 401.8 |
Dextran |
|||
| 10910-54 | NACALAI TESQUE | 5G | EUR 19.95 |
Dextran |
|||
| 10911-02 | NACALAI TESQUE | 25G | EUR 32.2 |
Dextran |
|||
| 10911-44 | NACALAI TESQUE | 5G | EUR 17.85 |
Dextran |
|||
| 10927-12 | NACALAI TESQUE | 25G | EUR 30.45 |
Dextran |
|||
| 10927-25 | NACALAI TESQUE | 500G | EUR 369.6 |
Dextran |
|||
| 10927-54 | NACALAI TESQUE | 100G | EUR 81.2 |
Dextran |
|||
| HY-112624 | MedChemExpress | 100mg | EUR 59.52 |
|
Description: Dextran (Dextran 40) has an inhibitory effect on thrombocyte aggregation and coagulation factors and is used as a plasma volume expander. |
|||
Dextran |
|||
| MBS5753006-100mg | MyBiosource | 100mg | EUR 145 |
Dextran |
|||
| MBS5753006-5x100mg | MyBiosource | 5x100mg | EUR 510 |
Dextran |
|||
| T11012-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Dextran |
|||
Dextran |
|||
| T11012-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Dextran |
|||
Dextran |
|||
| T11012-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Dextran |
|||
Dextran |
|||
| T11012-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Dextran |
|||
Dextran |
|||
| T11012-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Dextran |
|||
Dextran 10,000 |
|||
| GC0854 | Glentham Life Sciences | 25g | EUR 87.64 |
Dextran 10,000 |
|||
| GC0854-100 | Glentham Life Sciences | 100 | EUR 95.6 |
Dextran 10,000 |
|||
| GC0854-25 | Glentham Life Sciences | 25 | EUR 36.3 |
Dextran 4,000 |
|||
| GX1617 | Glentham Life Sciences | 25g | EUR 87.64 |
Dextran 1,000 |
|||
| GE1910 | Glentham Life Sciences | 100mg | EUR 506.81 |
Dextran 1,000 |
|||
| GE1910-1 | Glentham Life Sciences | 1 | EUR 150.4 |
Dextran 1,000 |
|||
| GE1910-100 | Glentham Life Sciences | 100 | EUR 34.1 |
Dextran 1,000 |
|||
| GE1910-100MG | Glentham Life Sciences | 100 mg | EUR 76.8 |
Dextran 1,000 |
|||
| GE1910-1G | Glentham Life Sciences | 1 g | EUR 217.2 |
Dextran 1,000 |
|||
| GE1910-5 | Glentham Life Sciences | 5 | EUR 553.6 |
Dextran 1,000 |
|||
| GE1910-500 | Glentham Life Sciences | 500 | EUR 87.1 |
Dextran 1,000 |
|||
| GE1910-500MG | Glentham Life Sciences | 500 mg | EUR 141.6 |
Dextran 1,000 |
|||
| GE1910-5G | Glentham Life Sciences | 5 g | EUR 705.6 |
Dextran 40,000 |
|||
| GE2215 | Glentham Life Sciences | 25g | EUR 282.53 |
Dextran 40,000 |
|||
| GE2215-100 | Glentham Life Sciences | 100 | EUR 95 |
Dextran 40,000 |
|||
| GE2215-100G | Glentham Life Sciences | 100 g | EUR 151.2 |
Dextran 40,000 |
|||
| GE2215-25 | Glentham Life Sciences | 25 | EUR 35.5 |
Dextran 40,000 |
|||
| GE2215-250 | Glentham Life Sciences | 250 | EUR 189.8 |
Dextran 40,000 |
|||
| GE2215-250G | Glentham Life Sciences | 250 g | EUR 265.2 |
Dextran 40,000 |
|||
| GE2215-25G | Glentham Life Sciences | 25 g | EUR 79.2 |
Dextran 40,000 |
|||
| GE2215-500 | Glentham Life Sciences | 500 | EUR 308.5 |
Dextran 40,000 |
|||
| GE2215-500G | Glentham Life Sciences | 500 g | EUR 409.2 |
Dextran 70,000 |
|||
| GE4231 | Glentham Life Sciences | 25g | EUR 217.3 |
